Physician profile
Dipti Itchhaporia
NPI 1316990070
$7,188.02
in general payments reported to CMS, 2019-2025
36 companies · $1,097 in 2025
The $1,097 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $137 · 2021: $473 · 2022: $3,664 · 2023: $828 · 2024: $789 · 2025: $1,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,699 · Entertainment: $15.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,698.62 |
| Entertainment | $15.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3,070.11 | 2022-2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $377.50 | 2019-2023 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $366.35 | 2019-2025 | Eliquis, Camzyos |
| Novo Nordisk INC | $345.28 | 2021-2025 | Ozempic, Wegovy |
| Cvrx, INC. | $335.04 | 2021-2025 | Barostim Neo System |
| Abbott Laboratories | $320.50 | 2021-2025 | Aveir, Jot Dx |
| Merck Sharp & Dohme LLC | $298.31 | 2021-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $266.64 | 2020-2025 | |
| Amgen INC. | $183.39 | 2025 | Repatha, Repatha |
| Medtronic, INC. | $156.99 | 2022-2025 | Micra, Tyrx, Attain Command + Surevalve |
| Janssen Biotech, INC. | $135.00 | 2025 | Tremfya |
| Biotronik INC. | $122.24 | 2019-2024 | Biomonitor |
| Heartflow, INC. | $107.12 | 2022-2024 | Ffrct |
| Boston Scientific Corporation | $93.70 | 2023-2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Bardy Diagnostics, INC. | $84.76 | 2020-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cmp Pharma, INC. | $83.20 | 2022-2023 | Norliqva, Carospir |
| Kestra Medical Technology Services, INC. | $77.95 | 2022-2025 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $75.13 | 2024 | Optimizer |
| Sanofi-Aventis U.S. LLC | $72.46 | 2021-2024 | |
| Bridgebio Pharma, INC. | $69.64 | 2025 | Attruby |
| Alnylam Pharmaceuticals INC. | $64.07 | 2021 | |
| Atricure, INC. | $61.23 | 2021-2022 | |
| Edwards Lifesciences Corporation | $57.19 | 2025 | |
| Esperion Therapeutics, INC. | $56.60 | 2022-2023 | Nexletol |
| Lundbeck LLC | $48.56 | 2019-2020 | |
| Coala Life INC | $36.33 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.79 | 2022 | |
| Azurity Pharmaceuticals, INC. | $31.63 | 2025 | Edarbi |
| Baxter Healthcare | $30.44 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Altathera Pharmaceuticals LLC | $22.49 | 2025 | Sotalol Hydrochloride |
| Infobionic, INC | $21.59 | 2024 | Mome Device |
| Cleerly, INC. | $17.86 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Medtronic Vascular, INC. | $17.71 | 2019 | |
| Kiniksa Pharmaceuticals, Ltd. | $16.29 | 2021 | |
| Opsens INC. | $15.08 | 2023 | Optowire |
| Actelion Pharmaceuticals US, INC. | $13.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dipti Itchhaporia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.